UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

The diagnostic value of the central vein sign in radiologically isolated syndrome

Annals of clinical and translational neurology, 2024-03, Vol.11 (3), p.662-672

2024

Link zum Volltext

Verfügbarkeit prüfen

Letter to the editor on “new algorithmic approach for easier and faster extended disability status scale calculation”

Multiple sclerosis journal - experimental, translational and clinical, 2023-07, Vol.9 (3), p.20552173231192941-20552173231192941

2023

Link zum Volltext

Verfügbarkeit prüfen

Radiologically isolated syndrome in the spectrum of multiple sclerosis

Multiple Sclerosis Journal, 2024-05, Vol.30 (6), p.630-636

2024

Link zum Volltext

Verfügbarkeit prüfen

Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

Annals of neurology, 2023-03, Vol.93 (3), p.604-614

2023

Link zum Volltext

Verfügbarkeit prüfen

European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

European journal of neurology, 2023-08, Vol.30 (8), p.2144-2176

2023

Link zum Volltext

Verfügbarkeit prüfen

Dental Adverse Effects of Anti-CD20 Therapies

Neurology and therapy, 2024-06, Vol.13 (3), p.917-930

2024

Link zum Volltext

Verfügbarkeit prüfen

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

Multiple Sclerosis Journal, 2023-07, Vol.29 (8), p.904-925

2023

Link zum Volltext

Verfügbarkeit prüfen

The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

Multiple sclerosis, 2022-08, Vol.28 (9), p.1424-1456

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

Lancet neurology, 2022-07, Vol.21 (7), p.608-619

2022

Link zum Volltext

Verfügbarkeit prüfen

MRI findings in blinded trials should be available to treating physicians – Yes

Multiple sclerosis, 2021-05, Vol.27 (6), p.812-813

2021

Link zum Volltext

Verfügbarkeit prüfen

Natural History of Multiple Sclerosis with Childhood Onset

The New England journal of medicine, 2007-06, Vol.356 (25), p.2603-2613

2007

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Simoa TM and Ella TM to assess serum neurofilament-light chain in multiple sclerosis

Annals of clinical and translational neurology, 2021-05, Vol.8 (5), p.1141-1150

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of SimoaTM and EllaTM to assess serum neurofilament‐light chain in multiple sclerosis

Annals of clinical and translational neurology, 2021-05, Vol.8 (5), p.1141-1150

2021

Link zum Volltext

Verfügbarkeit prüfen

Time to move past typical syndromes in the diagnosis of multiple sclerosis

Multiple sclerosis, 2024-05, p.13524585241253519-13524585241253519

2024

Link zum Volltext

Verfügbarkeit prüfen

Presymptomatic MS or radiologically isolated syndrome should be actively monitored and treated: Yes

Multiple sclerosis, 2023-06, Vol.29 (7), p.793-795

2023

Link zum Volltext

Verfügbarkeit prüfen

Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability

Multiple sclerosis and related disorders, 2021-09, Vol.54, p.103144-103144, Article 103144

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays

JAMA dermatology (Chicago, Ill.), 2014-08, Vol.150 (8), p.901

2014

Link zum Volltext

Verfügbarkeit prüfen

Vaccinations et sclérose en plaques : Recommandations de la Société Francophone de la Sclérose en Plaques (SFSEP)

Revue neurologique, 2019-04, Vol.175, p.S76-S77

2019

Link zum Volltext

Verfügbarkeit prüfen

Recommandations de la SFSEP « Infections et sclérose en plaques » : quel bilan préthérapeutique ?

Revue neurologique, 2021-04, Vol.177, p.S154-S154

2021

Link zum Volltext

Verfügbarkeit prüfen

Reply: Do we need new MRI criteria for the diagnosis of radiologically isolated syndrome?

Brain (London, England : 1878), 2023-11, Vol.146 (11), p.e104-e106

2023

Link zum Volltext

Verfügbarkeit prüfen

Faut-il traiter un syndrome radiologique isolé – synthèse

Revue neurologique, 2017-03, Vol.173, p.S191-S192

Lebrun-Frenay, Christine

2017

Link zum Volltext

Verfügbarkeit prüfen

Faut-il traiter un syndrome radiologique isolé – synthèse

Revue neurologique, 2017-03, Vol.173, p.S191-S192

Lebrun-Frenay, Christine

2017

Link zum Volltext

Verfügbarkeit prüfen

The multiple sclerosis prodrome is just unspecific symptoms in radiologically isolated syndrome patients – No

Multiple sclerosis, 2021-10, Vol.27 (12), p.1824-1826

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

ThemaLife Sciences

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Französisch
(57)
Englisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The diagnostic value of the central vein sign in radiologically isolated syndrome

Letter to the editor on “new algorithmic approach for easier and faster extended disability status scale calculation”

International consensus on quality standards for brain health-focused care in multiple sclerosis

Radiologically isolated syndrome in the spectrum of multiple sclerosis

Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

Matrix metalloproteinase 9 is decreased in natalizumab‐treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy

Dental Adverse Effects of Anti-CD20 Therapies

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

MRI findings in blinded trials should be available to treating physicians – Yes

Natural History of Multiple Sclerosis with Childhood Onset

Comparison of Simoa TM and Ella TM to assess serum neurofilament-light chain in multiple sclerosis

Comparison of SimoaTM and EllaTM to assess serum neurofilament‐light chain in multiple sclerosis

Time to move past typical syndromes in the diagnosis of multiple sclerosis

Presymptomatic MS or radiologically isolated syndrome should be actively monitored and treated: Yes

Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability

Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays

Vaccinations et sclérose en plaques : Recommandations de la Société Francophone de la Sclérose en Plaques (SFSEP)

Recommandations de la SFSEP « Infections et sclérose en plaques » : quel bilan préthérapeutique ?

Reply: Do we need new MRI criteria for the diagnosis of radiologically isolated syndrome?

Faut-il traiter un syndrome radiologique isolé – synthèse

Faut-il traiter un syndrome radiologique isolé – synthèse

The multiple sclerosis prodrome is just unspecific symptoms in radiologically isolated syndrome patients – No

Aktive Filter

Suchergebnisse filtern